Lung dysfunction of chronic smokers with no signs of COPD

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 8, Issue 3, 2011, Pages 189-195

  Nagelmann, Ave ^a,b   Tonnov, Äli ^b   Laks, Toivo ^a,b   Sepper, Ruth ^a   Prikk, Kaiu ^a  

^a TALLINN UNIVERSITY OF TECHNOLOGY   (Estonia)

^b North Estonia Medical Centre   (Estonia)

Author keywords

air trapping; airflow limitation; airway conductance and resistance; chronic smoking; lung hyperinflation

Indexed keywords

ADULT; AGED; AIRWAY CONDUCTANCE; AIRWAY OBSTRUCTION; ARTICLE; BODY PLETHYSMOGRAPHY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG DIFFUSION CAPACITY; LUNG DISEASE; LUNG EMPHYSEMA; MALE; PRIORITY JOURNAL; RESIDUAL VOLUME; SPIROMETRY; TOTAL LUNG CAPACITY;

ADULT; AGED; EARLY DIAGNOSIS; HUMANS; LUNG; LUNG VOLUME MEASUREMENTS; MALE; MIDDLE AGED; PLETHYSMOGRAPHY, WHOLE BODY; PULMONARY DIFFUSING CAPACITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; REGRESSION ANALYSIS; RESPIRATORY FUNCTION TESTS; SMOKING; SPIROMETRY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79957596005     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2011.565090     Document Type: Article

References (32)

1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease Available from www.goldcopd.com (2009 update).
2. Celli BR. Update on the management of COPD. Chest 2008; 133;1451-1462. (Pubitemid 351893003)
3. Mannino DM, Buist AS. Global burden of COPD: Risk factors, prevalence, and future trends. Lancet 2007; 370:765-773. (Pubitemid 47321908)
4. Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet 2009; 374:721-732.
5. Lee G, Walser TC, Dubinett SM. Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer. Curr Opin Pulm Med 2009; 15:303-307.
6. Yoshida T, Tuder RM. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiol Rev 2007; 87:1047-1082. (Pubitemid 47084676)
7. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Paré PD. Thenature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:2645-2653. (Pubitemid 38787999)
8. Stanescu D. Small airways obstruction syndrome. Chest 1999; 116: 231-233. (Pubitemid 29340287)
9. O'Donnell DE, Laveneziana P. Lung hyperinflation in COPD:The impact of pharmacotherapy Eur Respir Rev 2006; 15:85-89. (Pubitemid 47035707)
10. Blonshine S, Goldman MD. Optimizing performance of respiratory airflow resistance measurements. Chest 2008; 134:1304-1309.
11. Clayton N. Review series: Lung function made easy. Assessing lung size. Chronic Respiratory Disease 2007; 4:151-157.
12. Borill ZL, Roy K, Vessey RS, Woodcock AA, Singh D. Noninvasive biomarkers and pulmonary function test in smokers. Inter J COPD 2008; 3:171-183. (Pubitemid 351523730)
13. Kohansal R, Martinez-Camblor P, Agustí A, Buist AS, Mannino DM, Soriano JB. The natural history of chronic air flow obstruction revisited, An analysis of the Framingham offspring cohort. AmJ Respir Crit Care Med 2009; 180:3-10.
14. Gold PM. The 2007 GOLD Guidelines: A comprehensive care framework. Respir Care 2009; 54:1040-1049.
15. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977; 1:1645-1648. (Pubitemid 8124466)
16. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, Van Der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC,MacIntyre N,McKay R,Miller MR, Navajas D, Pedersen OF, Wanger J. Interpretative strategies for lung function tests. Eur Respir J 2005; 26:948-968. (Pubitemid 41632054)
17. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party, Standardization of Lung Function Tests". European Coal and Steel Community. Eur Respir J 1993; 6 (Suppl. 16):5-40.
18. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, Van Der Grinten CPM, Gustafsson P, Hankinson J, Jensen R, Johnson D, MacIntyre N, McKay R, Miller MR, Navajas D, Pellegrino R, Viegi G. Standardisation of the measurement of lung volumes. Series "ATS/ERS Task force: Standardization of lung function testing" Edited by V. Brusasco, R. Crapo and G. Viegi. Eur Respir J 2005; 26:511-522.
19. Goldman MD, Smith HJ, Ulmer WT. Whole-body plethysmography. Eur Respir Mon 2005; 31:15-43.
20. Albuquerque ALP, Nery LE, Villaça DS, Machado TYS, Oliveira CC, Paes AT, Neder JA. Inspiratory fraction and exercise impairment in COPD patients GOLD stages II-III. Eur Respir J 2006; 28:939-944. (Pubitemid 46331962)
21. Madama VC. Pulmonary Function Testing and Cardiopulmonary Stress Testing. Second Edition, New York: Delmar Publisher Team; 1998:100-105.
22. Irvin CG. Guide to the evaluation of pulmonary function. In. Hamid Q, Joanne Shannon J, Martin J. Physiologic Basis of Pulmonary Disease. Hamilton: BC Decker Inc.; 2005:649-658.
23. Parr DG, Stoel BC, Stolk J, Stockley RA. Pattern of emphysema distribution in alpha1-antitrypsin deficiency influences lung function impairment. Am J Respir Crit Care Med 2004; 170:1172-1178. (Pubitemid 39577374)
24. BrusascoV. Fitting JW. Lung hyperinflation in airway obstruction. Eur Respir J 1996; 9:2440. (Pubitemid 26407889)
25. Miller MR, Quanjer PH, Swanney MP, Ruppel G, Enright PL. Interpreting lung function data using 80 percent of predicted and fixed thresholds misclassifies over 20% of patients. Chest. 2010 [Epub ahead of print]
26. Hansen JE, Sun XG,Wasserman K. Spirometric criteria for airway obstruction: Use percentage of FEV1/FVC ratio below the fifth percentile, not < 70%. Chest. 2007; 131:349-355 (Pubitemid 46280391)
27. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructivepulmonary disease. N Engl J Med 2004; 350:1005-1012. (Pubitemid 38269277)
28. Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T, Sørensen TI, Lange P. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: Findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006; 173:79-83. (Pubitemid 43069791)
29. Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, KosiborodM, Portnay EL, Sokol SI, Bader F, KrumholzHM. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 2005; 165:55-61. (Pubitemid 40096082)
30. Poulain M, Doucet M, Drapeau V, Fournier G, Tremblay A, Poirier P, Maltais F. Metabolic and inflammatory profile in obese patientswith chronic obstructive pulmonary disease. Chron Respir Dis 2008; 5:35-41. (Pubitemid 351903614)
31. tenHackenNH. Physical inactivity and obesity: relation to asthma and chronic obstructive pulmonary disease?AmThorac Soc 2009; 6:663-667.
32. Ora J, Laveneziana P, Ofir D, Deesomchok A, Webb KA, O'Donnell DE. Combined Effects of Obesity and COPD on Dyspnea and Exercise Tolerance Amer J Respir Crit Care Med 2009; 180:964-971.